Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.55    0.10 (6.90%)
Bid:
1.40
Ask:
1.70
Spread: 0.30 (21.429%)
Market Cap: £13.36m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Result of Fundraise

30 Sep 2022 15:49

RNS Number : 4121B
Xeros Technology Group plc
30 September 2022
 

 

For immediate release

 

 

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF XEROS TECHNOLOGY GROUP PLC IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED AT 12.51 P.M. today.

 

30 September 2022

Xeros Technology Group plc

("Xeros", the "Group" or the "Company")

 

Result of Fundraising

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, is pleased to announce that further to the Company's announcement released at 12.51 p.m. today (the "Launch Announcement"), the Bookbuild has closed and the Company has conditionally raised gross proceeds of approximately £6.0 million, through the successful placing of 120,000,000 Placing Shares at the Issue Price of 5 pence per Ordinary Share.

In addition to the Placing, the Company intends to provide all Qualifying Shareholders with the opportunity to subscribe for an aggregate of up to 20,386,699 Open Offer Shares at the Issue Price, to raise up to approximately £1.0 million (before expenses), on the basis of 6 Open Offer Shares for every 7 Existing Ordinary Shares held on the Record Date. Qualifying Shareholders subscribing for their full entitlement under the Open Offer may also request additional Open Offer Shares through an excess application facility (the "Excess Application Facility").

The Placing and Open Offer are conditional upon, inter alia, the passing of the Resolutions at the General Meeting and upon the Placing Agreement becoming unconditional in all respects. The Placing is not conditional on the Open Offer proceeding or on any minimum take-up under the Open Offer.

General Meeting and Shareholder Approval

 

For the New Ordinary Shares to be admitted to trading on AIM, Shareholder approval is required:

 

a. by way of ordinary resolution to give the Directors authority to allot the New Ordinary Shares and issue the Warrants;

b. by way of special resolution to approve the Capital Reorganisation;

c. by way of special resolution to adopt New Articles, required in connection with the Capital Reorganisation; and

d. by way of a special resolution to dis-apply statutory pre-emption rights in respect of the New Ordinary Shares and the Warrants.

 

The authorities referred to above are in addition to the Company's existing general shareholder authorities to allot Ordinary Shares for cash on a non-pre-emptive basis.

 

In order to obtain the necessary shareholder approval, a General Meeting is to be held at the offices of Squire Patton Boggs (UK) LLP at Premier Place, 2 & A Half Devonshire Square, London EC2M 4UJ at 10.00 a.m. on 20 October 2022 at which the Resolutions will be proposed. A Circular containing a Notice of General Meeting is expected to be sent to shareholders on 3 October 2022. The shareholder Circular and Notice of General Meeting will be made available on the Company's website at www.xerostech.com.

 

Posting of Circular and Notice of General Meeting

The Company will post a Circular to Shareholders on 3 October 2022, containing a Notice of General Meeting, proxy form and full details of the Open Offer including the Open Offer application form. The Circular will also be available on the Company's website at www.xerostech.com.

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

2022

Record Date for entitlements under the Open Offer

Close of business on 29 Sep

Announce Launch of the Fundraising

30 Sep

Announce Close of the Fundraising

30 Sep

Ex-entitlement date for the Open Offer

8:00 a.m. 3 Oct

Publication and posting of the Circular, the Form of Proxy and, to Qualifying Non-CREST Shareholders only, Application Forms

3 Oct

Basic Entitlements and Excess Entitlements credited to stock accounts of qualifying CREST Shareholders

4 Oct

Recommended latest time for requesting withdrawal of Basic Entitlements and Excess Entitlements from CREST

4:30 p.m. 13 Oct

Latest time and date for depositing Basic Entitlements and Excess Entitlements into CREST

 

3:00 p.m. 14 Oct

Latest time and date for splitting of Application Forms (to satisfy bona fide market claims only)

3:00 p.m. 17 Oct

Latest time and date for receipt of Forms of Proxy or electronic proxy appointments for use at the General Meeting

10:00 a.m. 18 Oct

Latest time and date for receipt of completed Application Forms from Qualifying Non-CREST Shareholders and payment in full under the Open Offer or settlement of relevant CREST instructions (as appropriate)

11:00 a.m. 19 Oct

Announcement of the results of the Open Offer

19 Oct

General Meeting

10:00 a.m. 20 Oct

Announcement of the results of the General Meeting

20 Oct

Record Date for the Capital Reorganisation

Close of business on 20 Oct

Admission and commencement of dealings in the New Ordinary Shares on AIM

08:00 a.m. 21 Oct

New Ordinary Shares in uncertificated form expected to be credited to accounts in CREST (uncertificated holders only)

21 Oct

Expected date of despatch of definitive share certificates for the New Ordinary Shares in certificated form (certificated holders only) and certificates in respect of the Warrants

Within 10 business days of Admission

 

 Notes

1. Each of the times and dates set out in the above timetable and mentioned in this Document is subject to change by the Company (with the agreement of finnCap), in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service.

2. References to times in this Document are to London time (unless otherwise stated). 

 

 

Enquiries:

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Paul Denney, Chief Financial Officer

 

Tel: 0114 321 6328

finnCap (Nominated Adviser & Broker)

Julian Blunt / Teddy Whiley / George Dollemore, Corporate Finance

Andrew Burdis / Sunila de Silva, ECM

 

Tel: 020 7220 0500 

Yellow Jersey PR

Sarah Hollins / Lilian Filips / Laurie Gellhorn

Tel: 020 3004 9512

The notifications below are made in accordance with the requirements of the EU regulation on market abuse which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

a. Klaas de Boer

b. Neil Austin

c. Paul Denney

d. Rachel Nooney

 

 

 

2. 

Reason for the notification

 

a)

Position/status:

a. Chairman

b. Chief Executive Officer

c. Chief Finance Officer

d. Non-Executive Director

 

b)

Initial notification/Amendment:

Initial Notification

 

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name:

Xeros Technology Group plc

 

b)

LEI:

2138009F3U39GVY7DG06

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 15 pence per share

GB00BMGYBJ57

 

b)

Nature of the transaction:

Subscription for new shares

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

5 pence

a. 2,400,000

b. 200,000

c. 200,000

d. 200,000

 

d)

Aggregated information:

·Aggregated volume:

·Price:

See 4c) above

 

 

e)

Date of the transaction:

30 September 2022

 

f)

Place of the transaction:

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGFLDGDGZZM
Date   Source Headline
10th Jun 20263:11 pmRNSResult of AGM
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.